Evidence map›Paper›PMID 36243268›Full record

Trial reportNeuroImage2022

L-DOPA enhances neural direction signals in younger and older adults.

Christoph Koch, Christian Baeuchl, Franka Glöckner, Philipp Riedel, Johannes Petzold, Michael N Smolka, Shu-Chen Li, Nicolas W Schuck

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in NeuroImage, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Christoph KochMax Planck Research Group NeuroCode, Max Planck Institute for Human Development, Berlin, Germany; International Max Planck Research School on the Life Course, Max Planck Institute for Human Development, Berlin, Germany. Electronic address: koch@mpib-berlin.mpg.de.
Christian BaeuchlFaculty of Psychology, Chair of Lifespan Developmental Neuroscience, Technische Universität Dresden, Dresden, Germany.
Franka GlöcknerFaculty of Psychology, Chair of Lifespan Developmental Neuroscience, Technische Universität Dresden, Dresden, Germany.
Philipp RiedelDepartment of Psychiatry, Technische Universität Dresden, Dresden, Germany.
Johannes PetzoldDepartment of Psychiatry, Technische Universität Dresden, Dresden, Germany.
Michael N SmolkaDepartment of Psychiatry, Technische Universität Dresden, Dresden, Germany.
Shu-Chen LiFaculty of Psychology, Chair of Lifespan Developmental Neuroscience, Technische Universität Dresden, Dresden, Germany; Centre for Tactile Internet with Human-in-the-Loop (CeTI), Technische Universität, Dresden, Germany.
Nicolas W SchuckMax Planck Research Group NeuroCode, Max Planck Institute for Human Development, Berlin, Germany; Max Planck UCL Centre for Computational Psychiatry and Aging Research, Berlin, Germany; Institute of Psychology, Universität Hamburg, Hamburg, Germany.
Technische Universität Dresden · DEMax Planck Institute for Human Development · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies indicate a role of dopamine in spatial navigation. Although neural representations of direction are an important aspect of spatial cognition, it is not well understood whether dopamine directly affects these representations, or only impacts other aspects of spatial brain function. Moreover, both dopamine and spatial cognition decline sharply during age, raising the question which effect dopamine has on directional signals in the brain of older adults. To investigate these questions, we used a double-blind cross-over L-DOPA/Placebo intervention design in which 43 younger and 37 older adults navigated in a virtual spatial environment while undergoing functional magnetic resonance imaging (fMRI). We studied the effect of L-DOPA, a dopamine precursor, on fMRI activation patterns that encode spatial walking directions that have previously been shown to lose specificity with age. This was done in predefined regions of interest, including the early visual cortex, retrosplenial cortex, and hippocampus. Classification of brain activation patterns associated with different walking directions was improved across all regions following L-DOPA administration, suggesting that dopamine broadly enhances neural representations of direction. No evidence for differences between regions was found. In the hippocampus these results were found in both age groups, while in the retrosplenial cortex they were only observed in younger adults. Taken together, our study provides evidence for a link between dopamine and the specificity of neural responses during spatial navigation. SIGNIFICANCE STATEMENT: The sense of direction is an important aspect of spatial navigation, and neural representations of direction can be found throughout a large network of space-related brain regions. But what influences how well these representations track someone's true direction? Using a double-blind cross-over L-DOPA/Placebo intervention design, we find causal evidence that the neurotransmitter dopamine impacts the fidelity of direction selective neural representations in the human hippocampus and retrosplenial cortex. Interestingly, the effect of L-DOPA was either equally present or even smaller in older adults, despite the well-known age related decline of dopamine. These results provide novel insights into how dopamine shapes the neural representations that underlie spatial navigation.

Indexed as

LevodopaSpatial NavigationAgedBrain MappingDopamineHumansMagnetic Resonance ImagingDopamineLevodopaAgingDopaminefMRIMVPANeural dedifferentiationSpatial navigationTuning functions

Identifiers

PMID36243268
PMCPMC9771830
OpenAlexW4304890226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.